Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
895 | 10656 | 28.4 | 51% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
24 | 112627 | HYPERTENSION//JOURNAL OF HYPERTENSION//HEART FAILURE |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARVEDILOL | Author keyword | 316 | 50% | 4% | 459 |
2 | NEBIVOLOL | Author keyword | 235 | 64% | 2% | 229 |
3 | BETA BLOCKERS | Author keyword | 87 | 20% | 4% | 397 |
4 | METOPROLOL | Author keyword | 58 | 26% | 2% | 194 |
5 | BISOPROLOL | Author keyword | 56 | 41% | 1% | 104 |
6 | CELIPROLOL | Author keyword | 45 | 54% | 1% | 58 |
7 | ATENOLOL | Author keyword | 39 | 20% | 2% | 174 |
8 | BETA BLOCKER | Author keyword | 35 | 16% | 2% | 197 |
9 | BOPINDOLOL | Author keyword | 34 | 79% | 0% | 22 |
10 | DOXAZOSIN | Author keyword | 25 | 25% | 1% | 90 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARVEDILOL | 316 | 50% | 4% | 459 | Search CARVEDILOL | Search CARVEDILOL |
2 | NEBIVOLOL | 235 | 64% | 2% | 229 | Search NEBIVOLOL | Search NEBIVOLOL |
3 | BETA BLOCKERS | 87 | 20% | 4% | 397 | Search BETA+BLOCKERS | Search BETA+BLOCKERS |
4 | METOPROLOL | 58 | 26% | 2% | 194 | Search METOPROLOL | Search METOPROLOL |
5 | BISOPROLOL | 56 | 41% | 1% | 104 | Search BISOPROLOL | Search BISOPROLOL |
6 | CELIPROLOL | 45 | 54% | 1% | 58 | Search CELIPROLOL | Search CELIPROLOL |
7 | ATENOLOL | 39 | 20% | 2% | 174 | Search ATENOLOL | Search ATENOLOL |
8 | BETA BLOCKER | 35 | 16% | 2% | 197 | Search BETA+BLOCKER | Search BETA+BLOCKER |
9 | BOPINDOLOL | 34 | 79% | 0% | 22 | Search BOPINDOLOL | Search BOPINDOLOL |
10 | DOXAZOSIN | 25 | 25% | 1% | 90 | Search DOXAZOSIN | Search DOXAZOSIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METOPROLOL | 278 | 37% | 6% | 595 |
2 | CARVEDILOL | 187 | 33% | 4% | 465 |
3 | BUCINDOLOL | 108 | 75% | 1% | 78 |
4 | BETA ADRENOCEPTOR ANTAGONIST | 95 | 67% | 1% | 85 |
5 | ADRENERGIC BLOCKADE | 73 | 36% | 2% | 166 |
6 | MERIT HF | 71 | 47% | 1% | 114 |
7 | CARDIAC INSUFFICIENCY BISOPROLOL | 62 | 50% | 1% | 89 |
8 | ATENOLOL | 61 | 22% | 2% | 250 |
9 | RANDOMIZED INTERVENTION TRIAL | 59 | 45% | 1% | 98 |
10 | BETA BLOCKERS | 56 | 16% | 3% | 331 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
BETA-BLOCKADE DURING AND AFTER MYOCARDIAL-INFARCTION - AN OVERVIEW OF THE RANDOMIZED TRIALS | 1985 | 2072 | 36 | 83% |
beta-adrenergic receptor blockade in chronic heart failure | 2000 | 582 | 82 | 66% |
Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas | 2015 | 5 | 59 | 22% |
Heart Failure and Chronic Obstructive Pulmonary Disease | 2011 | 51 | 87 | 49% |
Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) | 2013 | 26 | 24 | 54% |
Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol | 2008 | 37 | 61 | 92% |
Carvedilol | 1998 | 163 | 60 | 80% |
Beta-blocker use and COPD mortality: a systematic review and meta-analysis | 2012 | 22 | 19 | 63% |
Expert consensus document on beta-adrenergic receptor blockers | 2004 | 249 | 173 | 36% |
beta-blocker therapy in heart failure - Scientific review | 2002 | 158 | 70 | 54% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED HOSP PHARM YAHATANISHI KU | 5 | 60% | 0.1% | 6 |
2 | CLIN SCI STUDY OPERAT | 3 | 57% | 0.0% | 4 |
3 | CLIN PHARMACOKINET MODELING SIMULAT | 3 | 43% | 0.1% | 6 |
4 | EDUC NATIONALITIES | 3 | 100% | 0.0% | 3 |
5 | PHYSIOPATHOL CLIN BIOCHEM | 3 | 38% | 0.1% | 6 |
6 | MICHIGAN HEART FAILURE TRANSPLANT CARE | 3 | 50% | 0.0% | 4 |
7 | CLIN PHARMACOL STAT PROGRAMMING | 2 | 38% | 0.0% | 5 |
8 | CARDIOL SPORT MED | 2 | 28% | 0.1% | 7 |
9 | ATLANTA VASC FDN | 2 | 67% | 0.0% | 2 |
10 | BIOMED SURG SCI MED D | 2 | 67% | 0.0% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016150 | TORASEMIDE//HYPERKALEMIA//FUROSEMIDE |
2 | 0.0000013808 | CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE |
3 | 0.0000013752 | LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER |
4 | 0.0000011968 | HEART FAILURE//NATRIURETIC PEPTIDES//B TYPE NATRIURETIC PEPTIDE |
5 | 0.0000010997 | DRUG INDUCED DEPRESSION//BUZEPIDE METHIODIDE//DEPRESSIVE DISORDER CHEMICALLY INDUCED |
6 | 0.0000010399 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
7 | 0.0000010189 | IVABRADINE//SINOATRIAL NODE//HCN CHANNELS |
8 | 0.0000009813 | LEFT VENTRICULAR HYPERTROPHY//POST EXERCISE HYPOTENSION//LEFT VENTRICULAR MASS |
9 | 0.0000009662 | MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL |
10 | 0.0000009047 | CHLOROETHYLCLONIDINE//ALPHA1 ADRENOCEPTOR SUBTYPE//BETA3 ADRENOCEPTORS |